Our finished drug exports which started in the early 2000s, have expanded to include a number of countries in Southeast Asia, the Middle East and Central America. In 2014, the export volume was $2.5 million. Along with our medicines and injectable exports produced in our sophisticated facilities, we have continued our efforts to export medical devices as well as health care products which are our new growth engine.